ZOM — Zomedica Cashflow Statement
0.000.00%
HealthcareSpeculativeSmall CapNeutral
- $191.48m
- $72.01m
- $18.93m
- 20
- 39
- 50
- 27
Annual cashflow statement for Zomedica, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -16.6 | -19.8 | -16.9 | -18.4 | -17 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 5.73 | 3.33 | 1.86 | 6.84 | 7.01 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.434 | 0.03 | -1.72 | -1.35 | -3.35 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -11.1 | -15.6 | -16.2 | -14.3 | -11.7 |
Capital Expenditures | -0.628 | -0.687 | -0.017 | -0.526 | -2.79 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.009 | 0 | 1.02 | -71.4 | -153 |
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.619 | -0.687 | 1.01 | -71.9 | -156 |
Financing Cash Flow Items | 8.22 | 2.29 | -5.11 | -14.3 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 10.3 | 14.9 | 76.7 | 219 | 0.008 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.51 | -1.43 | 61.5 | 133 | -168 |